Detalles de la búsqueda
1.
Plasma Aß42/Aß40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.
Alzheimers Dement
; 20(2): 1214-1224, 2024 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-37932961
2.
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
Alzheimers Dement
; 2024 Apr 17.
Artículo
Inglés
| MEDLINE | ID: mdl-38629508
3.
World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia.
Alzheimers Dement
; 16(7): 1078-1094, 2020 07.
Artículo
Inglés
| MEDLINE | ID: mdl-32627328
4.
Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment.
Alzheimers Res Ther
; 15(1): 88, 2023 05 02.
Artículo
Inglés
| MEDLINE | ID: mdl-37131229
5.
ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer's disease and Alzheimer's disease-related dementias clinical trails.
JAMIA Open
; 5(1): ooab119, 2022 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-35156002
6.
Corrigendum to: ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer's disease and Alzheimer's disease-related dementias clinical trials.
JAMIA Open
; 5(1): ooac008, 2022 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-35224459
7.
Early-stage Alzheimer disease: getting trial-ready.
Nat Rev Neurol
; 18(7): 389-399, 2022 07.
Artículo
Inglés
| MEDLINE | ID: mdl-35379951
8.
Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study.
Alzheimers Dement (N Y)
; 7(1): e12135, 2021.
Artículo
Inglés
| MEDLINE | ID: mdl-33778148
Resultados
1 -
8
de 8
1
Próxima >
>>